The use of apolipoprotein B in risk assessment

被引：0

|

作者：

不详

机构：

来源：

FUTURE CARDIOLOGY | 2006年 / 2卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：252 / 252

页数：1

相关论文

共 50 条

[1] Apolipoprotein B in cardiovascular risk assessment
Ahmad, Maud
Sniderman, Allan D.
Hegele, Robert A.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (33) : E1124 - E1124
[2] Apolipoprotein B in the assessment of cardiovascular risk
Ahmad, Maud
Sniderman, Allan D.
Hegele, Robert A.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (47) : E1644 - E1645
[3] Apolipoprotein B: its advantages in the assessment of atherosclerotic cardiovascular risk
Coniglio, Raul Ignacio
ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2021, 55 (01): : 11 - 20
[4] Comparative Assessment Of Hscrp And Apolipoprotein B As Ascvd Risk Biomarkers
Amusat, Saheed Oladele
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
[5] Comparative assessment of hsCRP and apolipoprotein B as ASCVD risk biomarkers
Amusat, S.
CLINICA CHIMICA ACTA, 2024, 558 : 48 - 48
[6] Comparative Assessment of hsCRP and Apolipoprotein B as ASCVD Risk Biomarkers
Amusat, Saheed Oladele
CIRCULATION, 2024, 150
[7] REFERENCE INTERVALS FOR APOLIPOPROTEIN A-I AND APOLIPOPROTEIN-B BY RATE NEPHELOMETRY AND ASSOCIATED CHD RISK ASSESSMENT
LOVE, JE
JONES, JT
MCGRATH, PC
MOORE, EC
CLINICAL CHEMISTRY, 1987, 33 (06) : 898 - 898
[8] Apolipoprotein E and apolipoprotein B genotypes and risk for spina bifida
Volcik, KA
Zhu, HP
Shaw, GM
Lammer, EJ
Finnell, RH
TERATOLOGY, 2002, 66 (05) : 257 - 259
[9] APOLIPOPROTEIN-B AND CARDIOVASCULAR RISK
CUVELIER, I
STEINMETZ, J
ANNALES DE BIOLOGIE CLINIQUE, 1982, 40 (04) : 440 - 440
[10] Integrated Measure for Atherogenic Lipoproteins in the Modern Era Risk Assessment Based on Apolipoprotein B
Rosenson, Robert S.
Hegele, Robert A.
Gotto, Antonio M., Jr.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (02) : 202 - 204

← 1 2 3 4 5 →